Immune response suppressor and treatment of multiple sclerosis

Details Immune response suppressor and treatment of multiple sclerosis Immune response suppressor and treatment of multiple sclerosis

A - Human Necessities

61

K

A61K 38/17 (2006.01) A61P 37/00 (2006.01)

Patent

CA 2568384

The present invention provides methods of treating multiple sclerosis, type 1 diabetes mellitus and other autoimmune diseases by administering a soluble immune response suppressor (SIRS) peptide or a variant thereof to an individual having such disease. The SIRS peptide or variant reduces the severity of or frequency of relapse of multiple sclerosis and reduces the inflammation associated with multiple sclerosis and other autoimmune diseases.

L'invention porte sur des méthodes de traitement de la sclérose en plaques, du diabète de type 1, ou d'autres maladies auto-immunes, par administration à un patient le nécessitant d'un peptide soluble suppresseur de la réponse immunitaire (SIRS), ou l'une de ses variantes, qui réduit la gravité ou la fréquence des rechutes de sclérose en plaques, et l'inflammation associé à cette maladie et à d'autres maladies auto-immunes.

Affiliated with

Also associated with

Rating

Immune response suppressor and treatment of multiple sclerosis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immune response suppressor and treatment of multiple sclerosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immune response suppressor and treatment of multiple sclerosis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1556713